Self-reported zidovudine adherence among pregnant women with human immunodeficiency virus infection in four US states
American Journal of Obstetrics and GynecologyPublished 1 May 2001
Tracey E. Wilson, Jeannette R. Ickovics, Mercedes Fernández, Linda J. Koenig, Emmanuel B. Walter
Citations33
SJR quartileQ1
SJR score2.77
SNIP2.75
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Zidovudine therapies have been successfully implemented in prenatal care settings in the United States, but the success of these therapies may be limited among some patients by incomplete regimen adherence, particularly among illicit drug users.
Abstract
Zidovudine therapies have been successfully implemented in prenatal care settings in the United States. The success of these therapies may be limited among some patients by incomplete regimen adherence, particularly among illicit drug users.
Keywords
Immunology and MicrobiologyMedicine
AIDS CareSelf-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments
1,442 Citations2000Margaret A. Chesney, Jeannette R. Ickovics +6 more
The AACTG Adherence Instruments, which are comprised of two self-report questionnaires for use in clinical trials conducted by the Adult AIDS Clinical Trials Group (AACTG), were administered to 75 patients in the USA.
New England Journal of MedicineMaternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant
811 Citations1996Rhoda Sperling, David E. Shapiro +16 more
To prevent HIV-1 transmission, initiating maternal treatment with zidovudine is recommended regardless of the plasma level of HIV- 1 RNA or the CD4+ count, and the reduction in viral RNA from base line to delivery was not significantly associated with the risk of transmission.
Clinical Infectious DiseasesFactors Affecting Adherence to Antiretroviral Therapy
706 Citations2000Margaret A. Chesney
The major reasons reported by HIV-infected individuals for not taking their medications are discussed, including substance and alcohol abuse and inconvenient dosing frequency, dietary restrictions, pill burden, and side effects.
AIDSThe value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response
548 Citations1999Richard Haubrich, Susan J. Little +8 more
Self-reported poor adherence and drug or alcohol use predicted non-response of HIV RNA at 6 months of antiretroviral therapy.
New England Journal of MedicineAbbreviated Regimens of Zidovudine Prophylaxis and Perinatal Transmission of the Human Immunodeficiency Virus
547 Citations1998Nancy A. Wade, Guthrie S. Birkhead +7 more
Journal of Clinical EpidemiologyAdherence in AIDS clinical trials: A framework for clinical research and clinical care
312 Citations1997Jeannette R. Ickovics, Andrew W. Meisler
A framework whereby factors affecting adherence in AIDS clinical trials can be categorized as characteristics of the individual, treatment regimen, patient-provider relationship, clinical setting, and disease is proposed, consistent with previous research on medical adherence.
JAMATrends in Perinatal Transmission of HIV/AIDS in the United States
291 Citations1999Mary Lou Lindegren
Substantial declines in AIDS incidence were temporally associated with an increase in zidovudine use to reduce perinatal HIV transmission, demonstrating substantial success in implementing PHS guidelines.
Social WorkGender Differences in Drug Addiction and Treatment: Implications for Social Work Intervention with Substance-Abusing Women
237 Citations1995Lani Nelson-Zlupko, Eda Kauffman +1 more
The article looks at traditional drug treatment programs, which have been designed to treat male addicts and fail to address the treatment needs of women, and offers an alternative treatment model designed to meet those needs.
JAMAThe Changing Pattern of Prenatal Care Utilization in the United States, 1981-1995, Using Different Prenatal Care Indices
224 Citations1998Michael D. Kogan
Annals of Internal MedicineViral Dynamics of HIV: Implications for Drug Development and Therapeutic Strategies
208 Citations1996Diane V. Havlir, Douglas D. Richman
The development of assays that detect and quantitate HIV in clinical specimens has permitted insights into viral burden, replication dynamics, and antiviral drug resistance in infected patients, and will support the implementation of earlier and more aggressive antiviral therapy for HIV infection.
JAMAPatient Compliance and Drug Failure in Protease Inhibitor Monotherapy
193 Citations1996Geertrui F. Vanhove
AIDSMaternal viral load and vertical transmission of HIV-1: an important factor but not the only one
176 Citations1999The European Collaborative Study
Mother-to-child transmission of HIV-1 is multi-factorial; high RNA load is an important determinant but clearly not the only one; Interventions that target risk factors other than maternal RNA load remain important.
PsycEXTRA DatasetU.S. Public Health Service Recommendations for Human Immunodeficiency Virus Counseling and Voluntary Testing for Pregnant Women
137 Citations1995Centers for Disease Control and Prevention (U.S.)
This document recommends routine HIV counseling and voluntary testing for all pregnant women and is intended to serve as guidance for health-care providers in educating women about the importance of knowing their HIV infection status.
AIDSThe effect of plasma drug concentrations on HIV-1 clearance rate during quadruple drug therapy
130 Citations1998Richard M. W. Hoetelmans, Monique H. Reijers +12 more
The variation in the rate of decline of plasma HIV-1 RNA between patients after the initiation of a quadruple drug regimen could be explained by differences in exposure to NFV or SQV.
Journal of Personality AssessmentAssessing Persons With Human Immunodeficiency Virus (HIV) Infection Using the Beck Depression Inventory: Disease Processes and Other Potential Confounds
118 Citations1995Seth C. Kalichman, Kathleen J. Sikkema +1 more
Results support the conclusion that depression scores require differential interpretations at different stages of HIV disease and that persons who have experienced HIV-related symptoms only be assessed for depression using instruments void of somatic symptoms.
AIDSPsychopathology in male and female HIV-positive and negative injecting drug users
117 Citations1997Judith G. Rabkin, Jeffrey G. Johnson +5 more
High rates of psychopathology were found in this IDU cohort, independent of HIV status and sex, and psychiatric services are indicated for this population of male and female HIV-positive injecting drug users.
Psychiatric ServicesAdequacy of Prenatal Care Among Women With Psychiatric Diagnoses Giving Birth in California in 1994 and 1995
98 Citations1999Rosemary Kelly, Beate Danielsen +4 more
Psychiatric diagnoses were associated with an increased risk of inadequate prenatal care; the association between psychiatric and substance use diagnoses and poor prenatal care persisted even after the analysis controlled for known risk factors.
Obstetrics and GynecologyAdherence to antiretroviral therapy by pregnant women infected with human immunodeficiency virus: a pharmacy claims-based analysis
94 Citations2000Christine Lainé
It was showed that most HIV-infected women adhered poorly and adherence did not improve over the 4-year study, whereas women already prescribed antiretrovirals before pregnancy had better adherence.
PubMedMedication adherence in patients with HIV infection: a comparison of two measurement methods.
75 Citations1999K M Melbourne, Sandra M. Geletko +4 more
Two measurements of adherence, patient self-report and electronic measurement by the Medication Event Monitoring System (MEMS), were compared in a 3-month adherence study of 44 HIV- infected patients who had been placed on regimens that included protease inhibitors (PIs).
JAMAZidovudine Use to Reduce Perinatal HIV Type 1 Transmission in an Urban Medical Center
56 Citations1996Andrew Wiznia
Zidovudine therapy to interrupt vertical transmission of HIV was not widely used by these HIV-infected pregnant women and further studies evaluating factors affecting the acceptance and use of recently published public health recommendations are needed.
JAIDS Journal of Acquired Immune Deficiency SyndromesBrief Report: Trends in Antiretroviral Therapy and Mother-Infant Transmission of HIV
44 Citations2000Ellen Cooper, Manhattan Charurat +3 more
A decline in mother-infant transmission was temporally associated with advances in therapy, especially when regimens including a protease inhibitor were included in the analysis.
Annals of Internal MedicineTranslating Clinical Trial Results into Practice: The Effect of an AIDS Clinical Trial on Prescribed Antiretroviral Therapy for HIV-Infected Pregnant Women
37 Citations1999Barbara J. Turner, Craig J. Newschaffer +3 more
Evaluated the pace at which prescribed antiretroviral treatment for HIV-infected pregnant women enrolled in the New York State Medicaid program changed after PACTG Protocol 076 and identified factors of health care delivery associated with early adoption of this new standard of care.
JAIDS Journal of Acquired Immune Deficiency SyndromesTrends in antiretroviral therapy and mother-infant transmission of HIV.
34 Citations2000EJward Cooper, Manhattan Charurat +3 more